ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
EXTENSION OF EXCLUSIVE AGREEMENT WITH BENE PHARMACHEM
Published: 29/09/20, 08:22am (AEST)•2 pages